Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study

Published: 10 June 2016
Author(s): Martin H. Ellis, Tsipora Neuman, Haim Bitterman, Sari Greenberg Dotan, Ariel Hammerman, Erez Battat, John W. Eikelboom, Jeffrey S. Ginsberg, Jack Hirsh
Issue: June 2016
Section: Original Article

Randomized controlled trials (RCTs) have shown that dabigatran, rivaroxaban and warfarin cause similar bleeding rates.